3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Mephentermine.
Acebutolol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Mephentermine.
Acepromazine
Acepromazine may decrease the stimulatory activities of Mephentermine.
Advertisement
Aceprometazine
Aceprometazine may decrease the stimulatory activities of Mephentermine.
Acetazolamide
Acetazolamide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Acetophenazine
Acetophenazine may decrease the stimulatory activities of Mephentermine.
Advertisement
Acrivastine
Mephentermine may decrease the sedative activities of Acrivastine.
Alcaftadine
Mephentermine may decrease the sedative activities of Alcaftadine.
Alfentanil
Mephentermine may increase the analgesic activities of Alfentanil.
Advertisement
Alfuzosin
Alfuzosin may decrease the vasoconstricting activities of Mephentermine.
Alphaprodine
Mephentermine may increase the analgesic activities of Alphaprodine.
Aluminum
Aluminium may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Aluminum Hydroxide
Aluminum hydroxide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
aluminum hydroxide, dried (USP)
Aluminum hydroxide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Aluminum Magnesium Silicate
Almasilate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Amineptin
Amineptine may increase the vasopressor activities of Mephentermine.
Amisulpride
Amisulpride may decrease the stimulatory activities of Mephentermine.
Amitriptyline
Amitriptyline may increase the vasopressor activities of Mephentermine.
Ammonium Chloride
The serum concentration of Mephentermine can be decreased when it is combined with Ammonium chloride.
Amoxapine
Amoxapine may increase the vasopressor activities of Mephentermine.
Amphetamine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Amphetamine.
Antazoline
Mephentermine may decrease the sedative activities of Antazoline.
Aripiprazole
Aripiprazole may decrease the stimulatory activities of Mephentermine.
Ascorbate
The serum concentration of Mephentermine can be decreased when it is combined with Vitamin C.
Ascorbic Acid
The serum concentration of Mephentermine can be decreased when it is combined with Vitamin C.
Asenapine
Asenapine may decrease the stimulatory activities of Mephentermine.
Astemizole
Mephentermine may decrease the sedative activities of Astemizole.
Atomoxetine
Atomoxetine may increase the hypertensive activities of Mephentermine.
Azatadine
Mephentermine may decrease the sedative activities of Azatadine.
Azelastine
Mephentermine may decrease the sedative activities of Azelastine.
Benperidol
Benperidol may decrease the stimulatory activities of Mephentermine.
Benzphetamine
The risk or severity of adverse effects can be increased when Benzphetamine is combined with Mephentermine.
Benztropine
Mephentermine may decrease the sedative activities of Benzatropine.
Benzylpenicilloyl polylysine
Mephentermine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
Bismuth Subcitrate
Bismuth Subcitrate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Brexpiprazole
Brexpiprazole may decrease the stimulatory activities of Mephentermine.
Bromocriptine
Bromocriptine may increase the hypertensive activities of Mephentermine.
Bromperidol
Bromperidol may decrease the stimulatory activities of Mephentermine.
Brompheniramine
Mephentermine may decrease the sedative activities of Brompheniramine.
Buclizine
Mephentermine may decrease the sedative activities of Buclizine.
Bunazosin
Bunazosin may decrease the vasoconstricting activities of Mephentermine.
Buprenorphine
Mephentermine may increase the analgesic activities of Buprenorphine.
Butorphanol
Mephentermine may increase the analgesic activities of Butorphanol.
Butyrate
Mephentermine may decrease the sedative activities of Butyric Acid.
Butyric Acid
Mephentermine may decrease the sedative activities of Butyric Acid.
Cabergoline
Cabergoline may increase the hypertensive activities of Mephentermine.
Calcium Carbonate
Calcium Carbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Carbinoxamine
Mephentermine may decrease the sedative activities of Carbinoxamine.
Cariprazine
Cariprazine may decrease the stimulatory activities of Mephentermine.
Carvedilol
Carvedilol may decrease the vasoconstricting activities of Mephentermine.
Celiprolol
The risk or severity of adverse effects can be increased when Mephentermine is combined with Celiprolol.
Cetirizine
Mephentermine may decrease the sedative activities of Cetirizine.
Chloropyramine
Mephentermine may decrease the sedative activities of Chloropyramine.
Chlorpheniramine
Mephentermine may decrease the sedative activities of Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
Mephentermine may decrease the sedative activities of Chlorphenamine.
Chlorphenoxamine
Mephentermine may decrease the sedative activities of Chlorphenoxamine.
Chlorpromazine
Chlorpromazine may decrease the stimulatory activities of Mephentermine.
Chlorprothixene
Chlorprothixene may decrease the stimulatory activities of Mephentermine.
Cimetidine
Mephentermine may decrease the sedative activities of Cimetidine.
Cinnarizine
Mephentermine may decrease the sedative activities of Cinnarizine.
Clemastine
Mephentermine may decrease the sedative activities of Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Mephentermine is combined with Clenbuterol.
Clomipramine
Clomipramine may increase the vasopressor activities of Mephentermine.
Clozapine
Clozapine may decrease the stimulatory activities of Mephentermine.
Codeine
Mephentermine may increase the analgesic activities of Codeine.
Codeine Anhydrous
Mephentermine may increase the analgesic activities of Codeine.
CODEINE POLISTIREX
Mephentermine may increase the analgesic activities of Codeine.
Cyamemazine
Cyamemazine may decrease the stimulatory activities of Mephentermine.
Cyclizine
Mephentermine may decrease the sedative activities of Cyclizine.
Cyclobenzaprine
Cyclobenzaprine may increase the vasopressor activities of Mephentermine.
Cyproheptadine
Mephentermine may decrease the sedative activities of Cyproheptadine.
Dapiprazole
Dapiprazole may decrease the stimulatory activities of Mephentermine.
Desipramine
Desipramine may increase the vasopressor activities of Mephentermine.
Desloratadine
Mephentermine may decrease the sedative activities of Desloratadine.
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Mephentermine.
Dexbrompheniramine
Mephentermine may decrease the sedative activities of Dexbrompheniramine.
Dexchlorpheniramine
Mephentermine may decrease the sedative activities of Dexchlorpheniramine.
Dexchlorpheniramine maleate
Mephentermine may decrease the sedative activities of Dexchlorpheniramine maleate.
Dextromoramide
Mephentermine may increase the analgesic activities of Dextromoramide.
Dezocine
Mephentermine may increase the analgesic activities of Dezocine.
Dichlorphenamide
Diclofenamide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Dihydrocodeine
Mephentermine may increase the analgesic activities of Dihydrocodeine.
Dihydroergotamine
Dihydroergotamine may increase the hypertensive activities of Mephentermine.
Dimenhydrinate
Mephentermine may decrease the sedative activities of Dimenhydrinate.
Dimethindene
Mephentermine may decrease the sedative activities of Dimetindene.
Diphenhydramine
Mephentermine may decrease the sedative activities of Diphenhydramine.
Diphenoxylate
Mephentermine may increase the analgesic activities of Diphenoxylate.
Dobutamine
The risk or severity of adverse effects can be increased when Dobutamine is combined with Mephentermine.
Dopamine
The risk or severity of adverse effects can be increased when Dopamine is combined with Mephentermine.
Dothiepin
Dosulepin may increase the vasopressor activities of Mephentermine.
Doxazosin
Doxazosin may decrease the vasoconstricting activities of Mephentermine.
Doxepin
Doxepin may increase the vasopressor activities of Mephentermine.
Doxylamine
Mephentermine may decrease the sedative activities of Doxylamine.
Droperidol
Droperidol may decrease the stimulatory activities of Mephentermine.
Duloxetine
Duloxetine may increase the tachycardic activities of Mephentermine.
Ebastine
Mephentermine may decrease the sedative activities of Ebastine.
Emedastine
Mephentermine may decrease the sedative activities of Emedastine.
Ephedrine
The risk or severity of adverse effects can be increased when Ephedrine is combined with Mephentermine.
Epinastine
Mephentermine may decrease the sedative activities of Epinastine.
Epinephrine
The risk or severity of adverse effects can be increased when Epinephrine is combined with Mephentermine.
ergoloid mesylates, USP
Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Mephentermine.
Ergonovine
Ergonovine may increase the hypertensive activities of Mephentermine.
Ergotamine
Ergotamine may increase the hypertensive activities of Mephentermine.
Ethosuximide
Mephentermine can cause a decrease in the absorption of Ethosuximide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ethylmorphine
Mephentermine may increase the analgesic activities of Ethylmorphine.
Etilefrine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Etilefrine.
Famotidine
Mephentermine may decrease the sedative activities of Famotidine.
Fenoterol
The risk or severity of adverse effects can be increased when Fenoterol is combined with Mephentermine.
Fentanyl
The serum concentration of Fentanyl can be decreased when it is combined with Mephentermine.
Fexofenadine
Mephentermine may decrease the sedative activities of Fexofenadine.
Flunarizine
Mephentermine may decrease the sedative activities of Flunarizine.
Flupenthixol
Flupentixol may decrease the stimulatory activities of Mephentermine.
Fluphenazine
Fluphenazine may decrease the stimulatory activities of Mephentermine.
Fluspirilene
Fluspirilene may decrease the stimulatory activities of Mephentermine.
Fonazine
Mephentermine may decrease the sedative activities of Dimetotiazine.
Furazolidone
Furazolidone may increase the hypertensive activities of Mephentermine.
Glutamate
The serum concentration of Mephentermine can be decreased when it is combined with Glutamic Acid.
Glutamic Acid
The serum concentration of Mephentermine can be decreased when it is combined with Glutamic Acid.
Guanethidine
The serum concentration of Mephentermine can be decreased when it is combined with Guanethidine.
Haloperidol
Haloperidol may decrease the stimulatory activities of Mephentermine.
Heroin
Mephentermine may increase the analgesic activities of Heroin.
Hyaluronidase
Hyaluronidase may increase the vasoconstricting activities of Mephentermine.
Hyaluronidase, Ovine
Hyaluronidase may increase the vasoconstricting activities of Mephentermine.
Hydrocodone
Mephentermine may increase the analgesic activities of Hydrocodone.
HYDROCODONE POLISTIREX
Mephentermine may increase the analgesic activities of Hydrocodone.
Hydromorphone
Mephentermine may increase the analgesic activities of Hydromorphone.
Hydrotalcite
Hydrotalcite may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Hydroxyzine
Mephentermine may decrease the sedative activities of Hydroxyzine.
Iloperidone
Iloperidone may decrease the stimulatory activities of Mephentermine.
Imipramine
Imipramine may increase the vasopressor activities of Mephentermine.
Indoramin
Indoramin may decrease the vasoconstricting activities of Mephentermine.
Ioflupane I-123
Mephentermine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Iproniazid
Iproniazid may increase the hypertensive activities of Mephentermine.
Isocarboxazid
Isocarboxazid may increase the hypertensive activities of Mephentermine.
Isoproterenol
The risk or severity of adverse effects can be increased when Isoprenaline is combined with Mephentermine.
Isothipendyl
Mephentermine may decrease the sedative activities of Isothipendyl.
Isoxsuprine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Isoxsuprine.
Ketotifen
Mephentermine may decrease the sedative activities of Ketotifen.
Labetalol
Labetalol may decrease the vasoconstricting activities of Mephentermine.
Levocabastine
Mephentermine may decrease the sedative activities of Levocabastine.
Levocetirizine
Mephentermine may decrease the sedative activities of Levocetirizine.
Levomethadyl
Mephentermine may increase the analgesic activities of Levomethadyl Acetate.
Levomilnacipran
Levomilnacipran may increase the tachycardic activities of Mephentermine.
Levorphanol
Mephentermine may increase the analgesic activities of Levorphanol.
Linezolid
Linezolid may increase the hypertensive activities of Mephentermine.
Lisuride
Lisuride may increase the hypertensive activities of Mephentermine.
Lithium
Lithium may decrease the stimulatory activities of Mephentermine.
Lithium Cation
Lithium may decrease the stimulatory activities of Mephentermine.
Lodoxamide
Mephentermine may decrease the sedative activities of Lodoxamide.
Loratadine
Mephentermine may decrease the sedative activities of Loratadine.
Loxapine
Loxapine may decrease the stimulatory activities of Mephentermine.
Lurasidone
Lurasidone may decrease the stimulatory activities of Mephentermine.
Magaldrate
Magaldrate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Magnesium Hydroxide
Magnesium hydroxide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Magnesium Oxide
Magnesium oxide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Magnesium Trisilicate
Magnesium Trisilicate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Meclizine
Mephentermine may decrease the sedative activities of Meclizine.
Meperidine
Mephentermine may increase the analgesic activities of Pethidine.
Mequitazine
Mephentermine may decrease the sedative activities of Mequitazine.
Mesoridazine
Mesoridazine may decrease the stimulatory activities of Mephentermine.
Metaproterenol
The risk or severity of adverse effects can be increased when Orciprenaline is combined with Mephentermine.
Metaraminol
The risk or severity of adverse effects can be increased when Metaraminol is combined with Mephentermine.
Metergoline
Metergoline may increase the hypertensive activities of Mephentermine.
Methadone
Mephentermine may increase the analgesic activities of Methadone.
Methadyl Acetate
Mephentermine may increase the analgesic activities of Methadyl Acetate.
Methamphetamine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Methamphetamine.
Methapyrilene
Mephentermine may decrease the sedative activities of Methapyrilene.
Methazolamide
Methazolamide may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Methenamine
The serum concentration of Mephentermine can be decreased when it is combined with Methenamine.
Methotrimeprazine
Methotrimeprazine may decrease the stimulatory activities of Mephentermine.
Methoxamine
The risk or severity of adverse effects can be increased when Methoxamine is combined with Mephentermine.
Methylene blue
The risk or severity of adverse effects can be increased when Mephentermine is combined with Methylene blue.
Methylergonovine
Methylergometrine may increase the hypertensive and vasoconstricting activities of Mephentermine.
Methysergide
Methysergide may increase the hypertensive activities of Mephentermine.
Metylperon
Melperone may decrease the stimulatory activities of Mephentermine.
Mianserin
Mephentermine may decrease the sedative activities of Mianserin.
Midodrine
The risk or severity of adverse effects can be increased when Midodrine is combined with Mephentermine.
Milnacipran
Milnacipran may increase the tachycardic activities of Mephentermine.
Minaprine
Minaprine may increase the hypertensive activities of Mephentermine.
Mirtazapine
Mirtazapine may increase the vasopressor activities of Mephentermine.
Mizolastine
Mephentermine may decrease the sedative activities of Mizolastine.
Moclobemide
Moclobemide may increase the hypertensive activities of Mephentermine.
Molindone
Molindone may decrease the stimulatory activities of Mephentermine.
Morphine
Mephentermine may increase the analgesic activities of Morphine.
Nabilone
Nabilone may increase the tachycardic activities of Mephentermine.
Nalbuphine
Mephentermine may increase the analgesic activities of Nalbuphine.
Nialamide
Nialamide may increase the hypertensive activities of Mephentermine.
Nicergoline
Nicergoline may increase the hypertensive activities of Mephentermine.
Nizatidine
Mephentermine may decrease the sedative activities of Nizatidine.
Norepinephrine
The risk or severity of adverse effects can be increased when Norepinephrine is combined with Mephentermine.
Normethadone
Mephentermine may increase the analgesic activities of Normethadone.
Nortriptyline
Nortriptyline may increase the vasopressor activities of Mephentermine.
Nylidrin
The risk or severity of adverse effects can be increased when Mephentermine is combined with Nylidrin.
Olanzapine
Olanzapine may decrease the stimulatory activities of Mephentermine.
Olopatadine
Mephentermine may decrease the sedative activities of Olopatadine.
Ondansetron
Ondansetron may decrease the stimulatory activities of Mephentermine.
Opipramol
Opipramol may increase the vasopressor activities of Mephentermine.
Opium
Mephentermine may increase the analgesic activities of Opium.
Oxatomide
Mephentermine may decrease the sedative activities of Oxatomide.
Oxycodone
Mephentermine may increase the analgesic activities of Oxycodone.
Oxymetazoline
The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Mephentermine.
Oxymorphone
Mephentermine may increase the analgesic activities of Oxymorphone.
p-Hydroxyamphetamine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Hydroxyamphetamine.
Paliperidone
Paliperidone may decrease the stimulatory activities of Mephentermine.
Paregoric
Mephentermine may increase the analgesic activities of Morphine.
Pargyline
Pargyline may increase the hypertensive activities of Mephentermine.
Pemirolast
Mephentermine may decrease the sedative activities of Pemirolast.
Pentazocine
Mephentermine may increase the analgesic activities of Pentazocine.
Perazine
Perazine may decrease the stimulatory activities of Mephentermine.
Pergolide
Pergolide may increase the hypertensive activities of Mephentermine.
Periciazine
Propericiazine may decrease the stimulatory activities of Mephentermine.
Perphenazine
Perphenazine may decrease the stimulatory activities of Mephentermine.
Phenelzine
Phenelzine may increase the hypertensive activities of Mephentermine.
Phenindamine
Mephentermine may decrease the sedative activities of Phenindamine.
Pheniramine
Mephentermine may decrease the sedative activities of Pheniramine.
Phenmetrazine
The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Mephentermine.
Phenobarbital
The serum concentration of Phenobarbital can be decreased when it is combined with Mephentermine.
Phentermine
The risk or severity of adverse effects can be increased when Phentermine is combined with Mephentermine.
PHENTERMINE RESIN
The risk or severity of adverse effects can be increased when Phentermine is combined with Mephentermine.
Phenylephrine
The risk or severity of adverse effects can be increased when Phenylephrine is combined with Mephentermine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Mephentermine.
Phenytoin
The serum concentration of Phenytoin can be decreased when it is combined with Mephentermine.
Pimozide
Pimozide may decrease the stimulatory activities of Mephentermine.
Pipamperone
Pipamperone may decrease the stimulatory activities of Mephentermine.
Pipothiazine
Pipotiazine may decrease the stimulatory activities of Mephentermine.
Pirinitramide
Mephentermine may increase the analgesic activities of Piritramide.
Prazosin
Prazosin may decrease the vasoconstricting activities of Mephentermine.
Procarbazine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Procarbazine.
Procaterol
The risk or severity of adverse effects can be increased when Mephentermine is combined with Procaterol.
Prochlorperazine
Prochlorperazine may decrease the stimulatory activities of Mephentermine.
Profenamine
Mephentermine may decrease the sedative activities of Ethopropazine.
Promazine
Promazine may decrease the stimulatory activities of Mephentermine.
Promethazine
Mephentermine may decrease the sedative activities of Promethazine.
Propoxyphene
Mephentermine may increase the analgesic activities of Dextropropoxyphene.
Prothipendyl
Prothipendyl may decrease the stimulatory activities of Mephentermine.
Protriptyline
Protriptyline may increase the vasopressor activities of Mephentermine.
Pseudoephedrine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Pseudoephedrine.
Pyrilamine
Mephentermine may decrease the sedative activities of Mepyramine.
Quetiapine
Quetiapine may decrease the stimulatory activities of Mephentermine.
Quetiapine fumarate
Quetiapine may decrease the stimulatory activities of Mephentermine.
Racepinephrine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Racepinephrine.
Ranitidine
Mephentermine may decrease the sedative activities of Ranitidine.
Rasagiline
Rasagiline may increase the hypertensive activities of Mephentermine.
Remifentanil
Mephentermine may increase the analgesic activities of Remifentanil.
Remoxipride
Remoxipride may decrease the stimulatory activities of Mephentermine.
Reserpine
Reserpine may decrease the stimulatory activities of Mephentermine.
Risperidone
Risperidone may decrease the stimulatory activities of Mephentermine.
Ritodrine
The risk or severity of adverse effects can be increased when Ritodrine is combined with Mephentermine.
Roxatidine Acetate
Mephentermine may decrease the sedative activities of Roxatidine acetate.
Selegiline
The risk or severity of adverse effects can be increased when Mephentermine is combined with Selegiline.
Sertindole
Sertindole may decrease the stimulatory activities of Mephentermine.
Silodosin
Silodosin may decrease the vasoconstricting activities of Mephentermine.
Sodium Bicarbonate
Sodium bicarbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Spironolactone
Spironolactone may decrease the vasoconstricting activities of Mephentermine.
Sufentanil
Mephentermine may increase the analgesic activities of Sufentanil.
Sulpiride
Sulpiride may decrease the stimulatory activities of Mephentermine.
Synephrine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Synephrine.
Tamsulosin
Tamsulosin may decrease the vasoconstricting activities of Mephentermine.
Tapentadol
Mephentermine may increase the analgesic activities of Tapentadol.
Tedizolid
Tedizolid Phosphate may increase the hypertensive activities of Mephentermine.
Tedizolid Phosphate
Tedizolid Phosphate may increase the hypertensive activities of Mephentermine.
Terazosin
Terazosin may decrease the vasoconstricting activities of Mephentermine.
Terbutaline
The risk or severity of adverse effects can be increased when Terbutaline is combined with Mephentermine.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Terbutaline is combined with Mephentermine.
Terfenadine
Mephentermine may decrease the sedative activities of Terfenadine.
Tetrahydrocannabinol
Dronabinol may increase the tachycardic activities of Mephentermine.
Tetrahydrozoline
The risk or severity of adverse effects can be increased when Mephentermine is combined with Tetryzoline.
Thioproperazine
Thioproperazine may decrease the stimulatory activities of Mephentermine.
Thioridazine
Thioridazine may decrease the stimulatory activities of Mephentermine.
Thiothixene
Thiothixene may decrease the stimulatory activities of Mephentermine.
Thonzylamine
Mephentermine may decrease the sedative activities of Thonzylamine.
Tianeptine
Tianeptine may increase the vasopressor activities of Mephentermine.
Tiapride
Tiapride may decrease the stimulatory activities of Mephentermine.
Toloxatone
Toloxatone may increase the hypertensive activities of Mephentermine.
Tramadol
Mephentermine may increase the analgesic activities of Tramadol.
Tramazoline
The risk or severity of adverse effects can be increased when Mephentermine is combined with Tramazoline.
Tranilast
Mephentermine may decrease the sedative activities of Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypertensive activities of Mephentermine.
Trifluoperazine
Trifluoperazine may decrease the stimulatory activities of Mephentermine.
Triflupromazine
Triflupromazine may decrease the stimulatory activities of Mephentermine.
Trimeprazine
Mephentermine may decrease the sedative activities of Alimemazine.
Trimipramine
Trimipramine may increase the vasopressor activities of Mephentermine.
Tripelennamine
Mephentermine may decrease the sedative activities of Tripelennamine.
Triprolidine
Mephentermine may decrease the sedative activities of Triprolidine.
Tromethamine
Tromethamine may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Tyramine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Tyramine.
Urapidil
Urapidil may decrease the vasoconstricting activities of Mephentermine.
Venlafaxine
Venlafaxine may increase the tachycardic activities of Mephentermine.
Ziprasidone
Ziprasidone may decrease the stimulatory activities of Mephentermine.
Zotepine
Zotepine may decrease the stimulatory activities of Mephentermine.
Zuclopenthixol
Zuclopenthixol may decrease the stimulatory activities of Mephentermine.
